Literature DB >> 11978809

Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics.

Marina R Picciotto1, William A Corrigall.   

Abstract

Nicotine addiction is a complex behavioral phenomenon comprising effects on several neural systems. Recent studies have expanded initial observations that the actions of nicotine on dopaminergic systems increase dopaminergic activity and release, leading to nicotine-induced reinforcement. Indeed, the actions of nicotine on many systems, including brainstem cholinergic, GABAergic, noradrenergic, and serotonergic nuclei, may help to mediate nicotine effects related to addiction. Furthermore, studies of mice lacking nicotinic acetylcholine receptor subunits or expressing supersensitive forms of these subunits have begun to tie together the molecular, neurochemical, and behavioral effects of nicotine. The use of multiple techniques by many laboratories provides optimism that the field is advancing toward elucidating the basic mechanisms of nicotine dependence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978809      PMCID: PMC6758396          DOI: 20026360

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons.

Authors:  C Léna; A de Kerchove D'Exaerde; M Cordero-Erausquin; N Le Novère; M del Mar Arroyo-Jimenez; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 2.  The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?

Authors:  D J Balfour; D L Ridley
Journal:  Pharmacol Biochem Behav       Date:  2000-05       Impact factor: 3.533

3.  Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum.

Authors:  F M Zhou; Y Liang; J A Dani
Journal:  Nat Neurosci       Date:  2001-12       Impact factor: 24.884

4.  Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion.

Authors:  N le Novère; M Zoli; C Léna; R Ferrari; M R Picciotto; E Merlo-Pich; J P Changeux
Journal:  Neuroreport       Date:  1999-08-20       Impact factor: 1.837

5.  Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety.

Authors:  C Labarca; J Schwarz; P Deshpande; S Schwarz; M W Nowak; C Fonck; R Nashmi; P Kofuji; H Dang; W Shi; M Fidan; B S Khakh; Z Chen; B J Bowers; J Boulter; J M Wehner; H A Lester
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

6.  Nicotine activates and desensitizes midbrain dopamine neurons.

Authors:  V I Pidoplichko; M DeBiasi; J T Williams; J A Dani
Journal:  Nature       Date:  1997-11-27       Impact factor: 49.962

7.  Long-term potentiation of excitatory inputs to brain reward areas by nicotine.

Authors:  H D Mansvelder; D S McGehee
Journal:  Neuron       Date:  2000-08       Impact factor: 17.173

8.  Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.

Authors:  P B Clarke; D S Fu; A Jakubovic; H C Fibiger
Journal:  J Pharmacol Exp Ther       Date:  1988-08       Impact factor: 4.030

9.  Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement.

Authors:  M C Olmstead; E M Munn; K B Franklin; R A Wise
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

10.  Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area.

Authors:  S A Oakman; P L Faris; P E Kerr; C Cozzari; B K Hartman
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

View more
  99 in total

Review 1.  A behavioral/systems approach to the neuroscience of drug addiction.

Authors:  Francis J White
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

2.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

3.  Differential cross-tolerance to the effects of nicotinic acetylcholine receptor drugs in C57BL/6J mice following chronic varenicline.

Authors:  Fernando B de Moura; Lance R McMahon
Journal:  Behav Pharmacol       Date:  2019-08       Impact factor: 2.293

4.  Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome.

Authors:  M Besson; V David; S Suarez; A Cormier; P Cazala; J-P Changeux; S Granon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

5.  Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration.

Authors:  Daniele Lecca; Fabio Cacciapaglia; Valentina Valentini; Janne Gronli; Saturnino Spiga; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-01-06       Impact factor: 4.530

Review 6.  A review of smoking cessation interventions.

Authors:  Ashish Maseeh; Gagandeep Kwatra
Journal:  MedGenMed       Date:  2005-06-07

7.  Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.

Authors:  Matthias E Liechti; Athina Markou
Journal:  Eur J Pharmacol       Date:  2006-10-17       Impact factor: 4.432

8.  A neurocomputational hypothesis for nicotine addiction.

Authors:  Boris S Gutkin; Stanislas Dehaene; Jean-Pierre Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

9.  Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.

Authors:  Andrés P Varani; Ester Aso; Lirane Machado Moutinho; Rafael Maldonado; Graciela N Balerio
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

10.  Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

Authors:  Edward D Levin; Susan Slade; Michael Johnson; Ann Petro; Kofi Horton; Paul Williams; Amir H Rezvani; Jed E Rose
Journal:  Eur J Pharmacol       Date:  2008-10-17       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.